IL10 and COVID-19: Pathway analysis of DEGs (padj < 0.1) between the SARS-CoV-2+ cells versus bystanders highlights the enrichment of pathways associated with IL-10 signaling (Fig. 5E, data file S7), which is consistent with up-regulation of this pathway in monocytes of patients with severe COVID-19 (71).